Clinical Trial Update: Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating induction chemotherapy with docetaxel, cisplatin, and fluorouracil with intensity-modulated radiotherapy for local recurrent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Hong Kong Nasopharyngeal Cancer Study Group Limited | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED